RET and thyroid gland disorder: In patients at increased risk of medullary thyroid cancer or mutations in the RET proto-oncogene and MEN2, as well as with a family history of thyroid diseases, prolonged use of GLP-1RA could contribute to the formation of thyroid tumors, particularly those originating from thyroid C-cells.